Bronze
NGeneBio was founded in 2015 as a spin-off venturefrom Korea Telecom (KT), develops in vitro diagnostics (IVD)/companiondiagnostics (CDx) products and bioinformatics SW with cutting-of-edgetechnologies including next generation sequencing (NGS). The company launchedNGS-based breast/ovarian cancer NGS panel (BRCAaccuTest™) withclinical analysis SW (NGeneAnalySys™) and received CE-IVD and KFDA approval in 2017. Additionally launchedNGS panels and SW for solid tumor (SOLIDaccuTest™) and hematological malignancies (HEMEaccuTest™, CE-IVD marked in 2018). Short Tandem Repeat(STR) kits, IDaccuTest™,compatible with Sanger sequencer for chimerism genetic testing aftertransplantation were also launched.